How to diagnose axial spondyloarthropathy early

Annals of the Rheumatic Diseases

Volumn 63, Issue 5, 2004, Pages 471-472

  Barkham, N ^a   Marzo Ortega, H ^a   McGonagle, D ^a   Emery, P ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ALGORITHM; ANKYLOSING SPONDYLITIS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EARLY DIAGNOSIS; GENERAL CONDITION IMPROVEMENT; HUMAN; IMAGING SYSTEM; PHYSIOTHERAPY; PRIORITY JOURNAL; RADIODIAGNOSIS; SACROILIAC JOINT; SHORT SURVEY; SPONDYLOARTHROPATHY; SYMPTOMATOLOGY; TREATMENT OUTCOME; X RAY;

DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMANS; SPONDYLARTHROPATHIES;

EID: 1942500387     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.014589     Document Type: Short Survey

References (17)

1. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. The prevalence of spondyloarthropathy in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
2. Barkham N, Kong K, Fraser A, Tennant A, Emery P. The unmet need for biologic therapy in ankylosing spondylitis [abstract]. ACR abstracts, 2003.
3. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997;36:766-71.
4. Carette S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983;26:186-90.
5. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-6.
6. Khan MA, Khan MK, Kushner I. Survival amongst patients with AS: a life-table analysis. J Rheumatol 1981;8:86-90.
7. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-14.
8. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M. Relative value of ESR and CRP in assesment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-4.
9. Oostveen J, Prevo R, den Boer J, van de Loar M. Early detection of sacroilitis on magnetic resonance imaging and subsequent development of sacroilitis on plain radiography, prospective, longitudinal study. J Rheumatol 1999;26:1953-8.
10. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept in the treatment of entheseal pathology in resistant spondyloarthropathy. Arthritis Rheum 2001;44:2112-17.
11. Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab. Arthritis Rheum 2003;48:1126-36.
12. st MISS study [abstract]. Arthritis Rheum 2002;46(suppl):S428.
13. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, et al. A 6 month randomised, controlled, double-blind, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of NSAID refractory AS. Arthritis Rheum 2002;46:766-73.
14. Sieper J, Braun J. New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis workshop, Berlin, Germany, 18-19 January 2002. Ann Rheum Dis 2002;61(suppl III):iii1-2.
15. Marzo-Ortega H, Emery P, McGonagle D. The concept of disease modification in spondyloarthropathy. J Rheumatol 2002;29:1583-5.
16. Quinn M, Conaghan P, Greenstein A, O'Connor P, Karim Z, Fraser A, et al. Sustained response in early poor prognosis RA after withdrawal of infliximab therapy [abstract]. Arthritis Rheum 2002;(suppl) abstr 6:3416.
17. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early? Ann Rheum Dis 2004;63:535-43.